外周血淋巴细胞/单核细胞比值与恶性胸膜间皮瘤患者预后的关系

doi:10.6040/j.issn.1671-7554.0.2016.355

摘要/Abstract

摘要： 目的探讨外周血淋巴细胞/单核细胞比值(LMR)与恶性胸膜间皮瘤(MPM)患者预后的关系。方法收集85例MPM患者的临床资料和随访资料,根据外周血LMR值将患者分为高LMR组(n=27)和低LMR组(n=58),对比分析两组临床病理资料和生存时间,并采用Cox回归模型分析LMR及其他临床病理因素与患者总生存期的关系。结果两组性别、功能状态(PS)评分、淋巴细胞计数和单核细胞计数差异有统计学意义(P<0.05)。高LMR组中位生存时间(27个月)显著长于低LMR组(9个月)(P<0.001)。在不同组织学类型和肿瘤分期患者中,高LMR组中位生存时间均长于低LMR组(P<0.05)。多因素分析显示,LMR是影响MPM患者总生存期的独立因素(HR: 0.277; 95% CI: 0.142~0.538; P<0.001)。结论外周血LMR可作为反映MPM患者生存预后的生物学标志物。

关键词: 总生存期, 胸腔镜, 淋巴细胞/单核细胞比值, 恶性胸膜间皮瘤, 预后

Abstract: Objective To explore the correlation between lymphocyte-to-monocyte ratio(LMR)in peripheral blood and prognosis of malignant pleural mesothelioma(MPM). Methods Clinicopathological data of 85 patients with MPM were retrospectively analyzed. According to the LMR in peripheral blood, the patients were divided into two groups: high LMR group(n=27)and low LMR group(n=58). The clinicopathological data and overall survival of the two groups were compared. The correlation between the clinicopathological data and the overall survival was analyzed with Cox regression model. Results Significant differences were observed between the two groups in gender, performance status(PS)score, absolute lymphocyte count and absolute monocyte count(P<0.05). The median overall survival of patients with high LMR was significantly longer than that of patients with low LMR(27 months vs 9 months, P<0.001). Of patients with various histological types and tumor stages, the median overall survival of patients with high LMR was significantly longer than that of patients with low LMR. Multivariate analysis showed that LMR was an independent prognostic factor associated with prognosis of MPM(HR: 0.277; 95% CI: 0.142-0.538; P<0.001). Conclusion LMR in peripheral blood is a biological marker for the prognosis of MPM.

Key words: Thoracoscopy, Lymphocyte-to-monocyte ratio, Malignant pleural mesothelioma, Prognosis, Overall survival

中图分类号:

R734.3

王雯,刘尧,龙飞,马卫霞,苏莉莉. 外周血淋巴细胞/单核细胞比值与恶性胸膜间皮瘤患者预后的关系[J]. 山东大学学报（医学版）, 2016, 54(8): 72-77.

WANG Wen, LIU Yao, LONG Fei, MA Weixia, SU Lili. Correlation between lymphocyte-to-monocyte ratio in peripheral blood and prognosis of malignant pleural mesothelioma[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(8): 72-77.

参考文献

[1] 曲宸绪, 周珊珊, 乔友林. 我国部分地区胸膜间皮瘤的描述流行病学分析[J]. 肿瘤研究与临床, 2004, 16(2): 143-144.
[2] 张盼, 王静. 胸膜间皮瘤的研究进展[J]. 肿瘤基础与临床, 2011, 24(1): 81-82.
[3] Nishijima TF, Muss HB, Shachar SS, et al. Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis[J]. Cancer Treat Rev, 2015, 41(10): 971-978.
[4] Cao C, Tian D, Park J, et al. A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma[J]. Lung Cancer, 2014, 83(2): 240-245.
[5] Rusch VW. A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group[J]. Chest, 1995, 108(4): 1122-1128.
[6] 郭靓, 钱露, 郭宁. 炎症——肿瘤恶性演进的推手[J]. 中国肿瘤生物治疗杂志, 2013, 20(3): 259-265. GUO Liang, QIAN Lu, GUO Ning. Inflammation: A promoter in malignant progression of tumor[J]. Chin J Cancer Biother, 2013, 20(3): 259-265.
[7] Li ZM, Huang JJ, Xia Y, et al. Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP[J]. PLoS ONE, 2012, 7(7): e41658. doi: 10.1371/journal.pone.0041658.
[8] Porrata LF, Ristow K, Colgan JP, et al. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkins lymphoma[J]. Haematologica, 2012, 97(2): 262-269.
[9] Stotz M, Szkandera J, Stojakovic T, et al. The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer[J]. Clin Chem Lab Med, 2015, 53(3): 499-506.
[10] Zhou X, Du Y, Xu J, et al. The preoperative lymphocyte to monocyte ratio predicts clinical outcomes in patients with stage Ⅱ/Ⅲ gastric cancer[J]. Tumour Biol, 2014, 35(11): 11659-11666.
[11] Hu P, Shen H, Wang G, et al. Prognostic significance of systemic inflammation-based lymphocyte- monocyte ratio in patients with lung cancer: based on a large cohort study[J]. PLoS ONE, 2014, 9(9): e108062. doi: 10.1371/journal.pone.0108062.
[12] Lin GN, Peng JW, Xiao JJ, et al. Prognostic impact of circulating monocytes and lymphocyte-to-monocyte ratio on previously untreated metastatic non-small cell lung cancer patients receiving platinum-based doublet[J]. Med Oncol, 2014, 31(7): 70.
[13] Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation[J]. Nature, 2008, 454(7203): 436-444.
[14] Coussens LM, Werb Z. Inflammation and cancer[J]. Nature, 2002, 420(6917): 860-867.
[15] Schmidt H, Bastholt L, Geertsen P, et al. Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model[J]. Br J Cancer, 2005, 93(3): 273-278.
[16] Lee YY, Choi CH, Sung CO, et al. Prognostic value of pretreatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level[J]. Gynecol Oncol, 2012, 124(1): 92-97.
[17] Koh YW, Shin SJ, Park C, et al. Absolute monocyte count predicts overall survival in mantle cell lymphomas: correlation with tumour-associated macrophages[J]. Hematol Oncol, 2014, 32(4): 178-186.
[18] Chanmee T, Ontong P, Konno K, et al. Tumor-associated macrophages as major players in the tumor microenvironment[J]. Cancers, 2014, 6(3): 1670-1690.

相关文章 15

[1]	栗英林,宋道庆,徐忠华. 应用生物信息学方法分析肾透明细胞癌中FKBP11的表达[J]. 山东大学学报 (医学版), 2020, 1(9): 45-51.
[2]	史爽,李娟,米琦,王允山,杜鲁涛,王传新. 胃癌miRNAs预后风险评分模型的构建与应用[J]. 山东大学学报 (医学版), 2020, 1(7): 47-52.
[3]	路璐,孙志钢,张楠. 继发性嗜血细胞综合征1例[J]. 山东大学学报 (医学版), 2020, 1(7): 122-124.
[4]	李星凯,刘战业,姜运峰,李军. 原发性中央型和周围型肺鳞癌临床病理学及预后差异[J]. 山东大学学报（医学版）, 2017, 55(9): 73-78.
[5]	聂思月,王震,孙靖宇,刘杰,李娟,魏小娟,路春晓,吕兴龑,王淑云,孙玉萍. ANGPTL5在人胃癌组织中的表达及临床意义[J]. 山东大学学报（医学版）, 2017, 55(8): 61-65.
[6]	宗帅,肖东杰,刘华,郏雁飞,马晓丽,李焕杰,黎娉,郑燕,汪运山. CSN5在胃癌中的表达及与患者预后的相关性[J]. 山东大学学报（医学版）, 2017, 55(7): 12-16.
[7]	孙启晶,陈方方,李春晓,张才擎. PNI及HGB评估中晚期非小细胞肺癌患者预后的临床价值[J]. 山东大学学报（医学版）, 2017, 55(4): 55-59.
[8]	王成,刘庆华,赵娜,姚周虹,万云焱,林殿杰. 内科胸腔镜诊治曲菌性脓胸2例[J]. 山东大学学报（医学版）, 2017, 55(4): 107-110.
[9]	董尧,宋亚林,田涛,高建国. 确诊8年未经治疗却无明显进展的阴茎恶性黑色素瘤1例报道[J]. 山东大学学报（医学版）, 2017, 55(3): 125-126.
[10]	林家香,郭子嘉,苏鹏,王晓,郭雅欣,吴晓娟,相磊,周志强, 王妍,崔秀杰,潘爱凤,郭成浩. 致癌蛋白CIP2A在乳腺导管上皮恶变中的作用及预测浸润性导管癌患者预后的能力[J]. 山东大学学报（医学版）, 2017, 55(3): 100-106.
[11]	周兰兰,潘学谊,郭煜. 48例急性混合细胞表型白血病患者的临床特征及预后[J]. 山东大学学报（医学版）, 2017, 55(2): 79-83.
[12]	张希英,翟春颜,李劲松,韩博. 中国尤文肉瘤患者EZH2蛋白表达与临床病理学参数及预后的关系[J]. 山东大学学报（医学版）, 2017, 55(2): 84-91.
[13]	刘惠苓,王兴文,冯少滨,冯虹,韩俊庆. B类I型清道夫受体的高表达与结肠癌患者预后的相关性[J]. 山东大学学报（医学版）, 2017, 55(10): 84-89.
[14]	刘松涛,沈斌,林辉,李香伟,温昭科. 全胸腔镜下心脏不停跳与停跳二尖瓣置换术的对比[J]. 山东大学学报（医学版）, 2016, 54(8): 39-43.
[15]	李晓宁,崔连群. 急性心肌梗死合并多支血管病变患者非梗死相关动脉处理的时机[J]. 山东大学学报（医学版）, 2016, 54(8): 50-54.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed